Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.  Lopes SS, Heo M, Pericot-Valverde I, Norton BL, Taylor LE, Tsui JI, Mehta SH, Feinberg J, K...

Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard?  Milošević I, Filipović A, Beronja B, Mitrović N, Ružić M, Simić J, Knežević N, Pete M, Todorović N, Nikolić N.  Microor...

Association between Chronic Hepatitis B/C and Incidence of Osteoporosis and Bone Fractures: Results from a Retrospective Cohort Study.  Loosen SH, Killer A, Bock HH, Luedde T, Roderburg C, Kostev K.  J Clin Med. 2024 Oct 16;13(20):6152...

Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study.  Olafsson S, Love TJ, Fridriksdottir RH, Tyrfingsson T, Runarsdottir V,...

Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain.  Ryan P, Valencia J, Sepúlveda-Crespo D, Amigot-Sánchez R, Cuevas G, Lazarus JV, Pérez-García F, Martínez I, Resino S.  JAMA Netw Open. 2024 Oct 1;7(1...

Hepatitis C Virus Infection in Europe.  Simão M, Gonçalves C.  Pathogens. 2024 Sep 28;13(10):841. doi: 10.3390/pathogens13100841. PMID: 39452713; PMCID: PMC11510056. https://pmc.ncbi.nlm.nih.gov/articles/PMC11510056/